GPR87

Across TCGA pan-cancer cohorts, GPR87 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated GPR87 data layer compared with 23 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher GPR87 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated GPR87 expression acts as an unfavorable survival marker.

CCRCC, GBM, and HNSC are the cancer types where GPR87 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	DFS	Median	II,III,IV	0.105	0.942	.002	42	view →
GBM	DFS	Tertile	All	0.242	0.492	.012	4	view →
HNSC	DFS	Quartile	II,III,IV	0.841	1.000	.045	1	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

GPR87–CCRCC (DFS)

Open the CCRCC breakdown →